Baicalin and taurine composition and application thereof in preparation of medicament

A composition, the technology of baicalin, which is applied in the field of baicalin and taurine composition, can solve the problems of limited curative effect, and achieve the effects of good prevention and treatment, strong antioxidant activity and antiviral effect

Active Publication Date: 2013-07-10
JIANGZI QINGFENG PHARMACEUTICALS INC
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Based on efficacy and safety data, several drugs have been approved for improving the symptoms of Alzheimer's dementia, such as donepezil (Aricept), rivastigmine, galanne, which are cholinesterase inhibitors Tamin and memantine, which are glutamate receptor antagonists, have limited curative effects and need to be combined with other drugs to achieve long-term therapeutic effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Baicalin and taurine composition and application thereof in preparation of medicament
  • Baicalin and taurine composition and application thereof in preparation of medicament
  • Baicalin and taurine composition and application thereof in preparation of medicament

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Mix baicalin (115.2g) and taurine (76.8g) at a ratio of 3:2, stir, grind, and mix uniformly to obtain a composition of baicalin and taurine (192g).

Embodiment 2

[0034] Mix baicalin (144g) and taurine (24g) at a ratio of 6:1, stir, grind, and mix uniformly to obtain a composition of baicalin and taurine (168g).

Embodiment 3

[0036] Mix baicalin (180g) and taurine (20g) at a ratio of 9:1, stir, grind, and mix uniformly to obtain a composition of baicalin and taurine (200g).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a baicalin and taurine medicinal composition capable of protecting neurocyte injury, improving the learning and memory ability and improving the cognition impairment so as to prevent and treat dementia.

Description

technical field [0001] The invention relates to a composition of baicalin and taurine and its application for preparing medicine. Background technique [0002] Dementia is a degenerative disease of the central nervous system that often occurs in old age and pre-senile age. The occupational and social life function of the patient is reduced or lost until death. In recent years, with the increase in the average life expectancy of the world's population and the intensification of the aging problem, its incidence has shown an upward trend year by year, and its impact on the quality of human life and even the threat to survival have become increasingly apparent. The average survival period of dementia patients is only 5-6 years, and it has become the fourth leading cause of death in the elderly after cardiovascular disease, cancer, and cerebrovascular disease. [0003] According to etiology, clinical manifestations, lesions, etc., it can be divided into different dementia subty...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61P25/28A61K31/185
Inventor 杨小玲张占军谢宁吕武清刘地发程帆王章伟欧阳婷蒋春红王燕平崔刚
Owner JIANGZI QINGFENG PHARMACEUTICALS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products